226 related articles for article (PubMed ID: 20572800)
1. Primary hematolymphoid malignancies involving the extrahepatic bile duct or gallbladder.
Hwang DW; Lim CS; Jang JY; Lee SE; Yoon SO; Jeon YK; Uk Lee K; Kim SW
Leuk Lymphoma; 2010 Jul; 51(7):1278-87. PubMed ID: 20572800
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and management of carcinomas of the gallbladder and extrahepatic bile ducts.
Lee RG; Emond J
Surg Oncol Clin N Am; 1997 Jul; 6(3):639-59. PubMed ID: 9210359
[TBL] [Abstract][Full Text] [Related]
3. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
[TBL] [Abstract][Full Text] [Related]
4. Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications.
Mani H; Climent F; Colomo L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2010 Sep; 34(9):1277-86. PubMed ID: 20679881
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic precursors of the gallbladder and extrahepatic biliary system.
Adsay NV
Gastroenterol Clin North Am; 2007 Dec; 36(4):889-900, vii. PubMed ID: 17996796
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
Itoh H; Nishijima K; Kurosaka Y; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Saitoh Y
Dig Dis Sci; 2005 Dec; 50(12):2231-42. PubMed ID: 16416167
[TBL] [Abstract][Full Text] [Related]
7. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma of the gallbladder and extrahepatic bile ducts.
Ferluga D; Luzar B; Gadzijev EM
Virchows Arch; 2003 Feb; 442(2):136-40. PubMed ID: 12596064
[TBL] [Abstract][Full Text] [Related]
9. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
[TBL] [Abstract][Full Text] [Related]
10. Synchronous primary tumors of the extrahepatic bile duct and gallbladder.
Kurosaki I; Watanabe H; Tsukada K; Hatakeyama K
J Surg Oncol; 1997 Aug; 65(4):258-62. PubMed ID: 9274790
[TBL] [Abstract][Full Text] [Related]
11. DNA image analysis study of lesions of the gallbladder and biliary system.
Brunt EM; Kraemer BB
Liver Transpl Surg; 1996 Jul; 2(4):284-9. PubMed ID: 9346662
[TBL] [Abstract][Full Text] [Related]
12. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer.
Lim CS; Jang JY; Lee SE; Kang MJ; Kim SW
J Gastrointest Surg; 2012 May; 16(5):1012-8. PubMed ID: 22271243
[TBL] [Abstract][Full Text] [Related]
13. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
14. Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.
Pandey D; Garg PK; Manjunath NM; Sharma J
J Gastrointest Cancer; 2015 Sep; 46(3):291-6. PubMed ID: 26049726
[TBL] [Abstract][Full Text] [Related]
15. Pathological features and surgical outcome of pancreaticobiliary maljunction without dilatation of the extrahepatic bile duct.
Tsuchida A; Itoi T; Endo M; Kitamura K; Mukaide M; Itokawa F; Ozawa T; Aoki T
Oncol Rep; 2004 Feb; 11(2):269-76. PubMed ID: 14719053
[TBL] [Abstract][Full Text] [Related]
16. Synchronous malignancies of the gall bladder and common bile duct: a case report.
Kodaganur S; Hosamani IR
World J Surg Oncol; 2016 Apr; 14():106. PubMed ID: 27059701
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of advanced gallbladder cancer involving the extrahepatic bile duct with neoadjuvant chemoradiation therapy - a case report].
Gotoh K; Marubashi S; Kobayashi S; Takahashi H; Akita H; Sugimura K; Miyoshi N; Motoori M; Kishi K; Noura S; Fujiwara Y; Ohue M; Tomita Y; Yano M; Ishikawa O; Sakon M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1515-7. PubMed ID: 25731237
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.
Harder J; Müller MJ; Fuchs M; Gumpp V; Schmitt-Graeff A; Fischer R; Frank M; Opitz O; Hasskarl J
World J Gastroenterol; 2013 Dec; 19(48):9334-42. PubMed ID: 24409060
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
20. An extrahepatic bile duct metastasis from a gallbladder cancer mimicking Mirizzi's syndrome.
Akiyama H; Sato T; Toyoda S; Yamada H
Am J Gastroenterol; 1999 Feb; 94(2):508-10. PubMed ID: 10022655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
